Regulation of Renal Hemodyamics by Purinergic Receptors in Angiotensin II -Induced Hypertension

क्यूआर कोड

Regulation of Renal Hemodyamics by Purinergic Receptors in Angiotensin II -Induced Hypertension

None

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखकों:	Franco, Martha, Bautista-Pérez, Rocío, Pérez-Méndez, Oscar
स्वरूप:	इलेक्ट्रोनिक पुस्तक अध्याय
भाषा:	अंग्रेज़ी
प्रकाशित:	IntechOpen 2012
विषय:	Health Sciences
ऑनलाइन पहुंच:	https://www.intechopen.com/chapters/36120
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

Radioligands Targeting the Purinergic P2X Receptors
द्वारा: Diego Dal Ben, और अन्य
प्रकाशित: (2025-06-01)

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS
द्वारा: D. V. Nebieridze
प्रकाशित: (2002-02-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
द्वारा: S. A. Boytsov, और अन्य
प्रकाशित: (2016-01-01)

PURINERGIC REGULATION OF BASIC PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES
द्वारा: A. S. Golovkin, और अन्य
प्रकाशित: (2018-06-01)

Facilitation of Neurotransmitter and Hormone Release by P2X Purinergic Receptors
द्वारा: Vavra, Vojtech, और अन्य
प्रकाशित: (2012)

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists
द्वारा: E. O. Taratukhin
प्रकाशित: (2012-12-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
द्वारा: R. D. Smith, और अन्य
प्रकाशित: (2010-12-01)

Metabolic syndrome and angiotensin II receptor antagonists
द्वारा: K. M. Mamyrbayeva, और अन्य
प्रकाशित: (2007-04-01)

Angiotensin II receptor inhibitors: role and place in arterial hypertension and metabolic syndrome treatment
द्वारा: I. N. Medvedev, और अन्य
प्रकाशित: (2007-10-01)

The Involvement of Purinergic System in Pain: Adenosine Receptors and Inosine as Pharmacological Tools in Future Treatments
द्वारा: Nascimento, Francisney Pinto, और अन्य
प्रकाशित: (2012)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
द्वारा: Mingfei Li, और अन्य
प्रकाशित: (2021-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
द्वारा: V. V. Fomin
प्रकाशित: (2013-08-01)

Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
द्वारा: Danilo Fliser, और अन्य
प्रकाशित: (1970-01-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
द्वारा: V. V. Fomin, और अन्य
प्रकाशित: (2007-06-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
द्वारा: Sh. V. Akhadov, और अन्य
प्रकाशित: (2011-02-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
द्वारा: M. L. Maksimov, और अन्य
प्रकाशित: (2010-04-01)

Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
द्वारा: B. Sh. Karimova, और अन्य
प्रकाशित: (2005-02-01)

Angiotensin II receptor antagonists – we have moved closer to the patient
द्वारा: L. G. Ratova, और अन्य
प्रकाशित: (2005-04-01)

ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
द्वारा: I. S. Mykhailichenko
प्रकाशित: (2016-04-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
द्वारा: S. V. Nedogoda, और अन्य
प्रकाशित: (2007-06-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists
द्वारा: Pertseva N.O.
प्रकाशित: (2016-06-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists.
द्वारा: N. O. Pertseva
प्रकाशित: (2016-06-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
द्वारा: E. V. Rebrova, और अन्य
प्रकाशित: (2024-01-01)

Expression of angiotensin II type 2 receptors and syndecan-1 in prostate cancer
द्वारा: E. A. Chernogubova, और अन्य
प्रकाशित: (2024-11-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
द्वारा: D. A. Sychev, और अन्य
प्रकाशित: (2006-04-01)

INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS
द्वारा: V. V. Fomin
प्रकाशित: (2016-01-01)

Gene polymorphism of endothelial NO-synthase, angiotensin-converting enzyme and receptors of angiotensin II type 1 in patients with coronary artery disease and type II diabetes.
द्वारा: L. M. Yakovleva
प्रकाशित: (2013-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
द्वारा: Shuichi Ichikawa, और अन्य
प्रकाशित: (2011-06-01)

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
द्वारा: A. V. Shabalin, और अन्य
प्रकाशित: (2005-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
द्वारा: K. A. Ghyamdzhyan, और अन्य
प्रकाशित: (2012-09-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
द्वारा: E. M. Khurs, और अन्य
प्रकाशित: (2016-01-01)

CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS
द्वारा: V. S. Zadionchenko, और अन्य
प्रकाशित: (2015-12-01)

EFFICACY AND SAFE USE OF SPECIFIC ANGIOTENSIN II RECEPTOR ANTAGONIST IRBESARTAN FOR CURING ARTERIAL HYPERTENSION IN CHILDREN AND TEENAGERS: A CLINICAL STUDY
द्वारा: L.P. Zharkova, और अन्य
प्रकाशित: (2007-05-01)

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
द्वारा: E. O. Taratukhin
प्रकाशित: (2013-06-01)

Difficult choice: angiotensin receptor antagonists
द्वारा: E. O. Taratukhin
प्रकाशित: (2013-04-01)

Angiotensin Receptor Blockade Does Not Decrease Synthetic Angiotensin II (Giapreza<sup>®</sup>) Effectiveness in Perioperative Hypotension Surrounding Kidney Transplant
द्वारा: Natalie Pettit, और अन्य
प्रकाशित: (2025-06-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
द्वारा: O. P. Shevchenko, और अन्य
प्रकाशित: (2016-01-01)

Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke
द्वारा: O. A. Osipova, और अन्य
प्रकाशित: (2021-11-01)

Association of angiotensinogen and angiotensin II receptor type I polymorphisms with biomarkers of carbohydrate and lipid metabolism in Dagestan residents with type 2 diabetes and hypertension
द्वारा: M. Z. Saidov, और अन्य
प्रकाशित: (2021-11-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
द्वारा: S. N. Tolpygina, और अन्य
प्रकाशित: (2016-01-01)